Skip to main content

Table 2 Baseline laboratory test information

From: Effects of COVID-19 infection in patients with autoimmune pulmonary alveolar proteinosis: a single-center study

Variables

All (n = 39)

Decreased oxygen saturation (n = 12)

Non decreased oxygen saturation (n = 27)

P value

Arterial blood gas

 pH

7.41 ± 0.02

7.41 ± 0.03

7.41 ± 0.02

0.351

 PaCO2 (mmHg)

37.56 ± 3.11

37.92 ± 2.35

37.40 ± 3.42

0.639

 PaO2 (mmHg)

82.80 ± 13.50

74.50 ± 13.61

86.49 ± 11.92

0.009

 SaO2 (%)

96.5 (95.3, 97.7)

95.4 (93.4, 97.7)

96.5 (95.7, 97.7)

0.245

 A-aDO2 (mmHg)

21.8 (9.6, 31.2)

26.8 (16.0, 42.9)

21.8 (8.9, 27.7)

0.159

 HCO3 (mmol/L)

23.04 ± 1.85

23.48 ± 1.62

22.85 ± 1.94

0.339

Serology

 HGB (g/L)

158.36 ± 17.77

155.25 ± 21.39

159.74 ± 16.18

0.474

 RBC# (× 1012/L)

5.21 ± 0.61

5.10 ± 0.82

5.26 ± 0.51

0.456

 HCT (%)

45.65 ± 4.76

44.78 ± 6.00

46.04 ± 4.17

0.454

 CEA (ng/ml)

4.00 (2.43, 7.60)

4.00 (2.29, 20.40)

3.90 (2.43, 7.30)

0.298

 Cyfra21-1 (ng/ml)

4.60 (2.60, 9.50)

7.05 (4.00, 11.70)

3.60 (2.30, 7.52)

0.072

 LDH (U/L)

243 (204, 350)

298 (234, 377)

218 (197, 309)

0.037

Pulmonary function

 FEV1 pred (%)

88.0 (75.5, 99.2)

90.0 (67.0, 104.7)

88.0 (77.0, 98.0)

0.799

 FVC pred (%)

91.0 (77.0, 101.0)

86.0 (68.3, 105.5)

95.0 (78.0,101.0)

0.753

 FEV1/FVC (%)

81.5 (77.9, 87.0)

83.6 (81.1, 87.8)

80.3 (76.8, 86.8)

0.221

 TLC pred (%)

85.0 (73.0, 94.0)

83.9 (65.7, 103.7)

85.0 (77.0, 94.0)

0.799

 RV pred (%)

86.0 (71.0, 99.0)

91.0 (73.6, 105.8)

85.0 (68.5, 99.0)

0.822

 DLCO pred (%)

68.3 (52.1, 81.8)

63.3 (44.9, 83.8)

69.6 (63.2, 80.5)

0.284

 DLCO/VA pred (%)

83.8 (75.4, 97.4)

77.0 (74.3, 93.6)

89.5 (78.2, 97.4)

0.036

 6MWD (m)

512 (463, 570)

464 (406, 538)

532 (470, 575)

0.028

 Borg at the end of 6MWD

1 (0, 2)

1 (0, 3)

0 (0, 2)

0.538

 SGRQ

 Symptom

28 (12, 47)

43 (27, 69)

24 (9, 36)

0.010

 Activity

29 (17, 47)

56 (23, 82)

23 (6, 36)

0.005

 Impact

14 (1, 43)

40 (13, 56)

9 (0, 23)

0.022

 Total

21 (9, 51)

46 (20, 64)

19 (8, 26)

0.009

DSS

0.017

 1

13 (33.3%)

1 (8.3%)

12 (44.4%)

 

 2

20 (51.3%)

7 (58.3%)

13 (48.1%)

 

 ≥ 3

6 (15.4%)

4 (33.3%)

2 (7.4%)

 
  1. 6MWD 6 min walking distance (test), A-aDO2 Alveolar arterial oxygen gradient, CEA Carcinoembryonic antigen, Cyfra21-1 Cytokeratin 19 fragment antigen21-1, DLCO Diffusing capacity for carbon monoxide, DLCO/VA Diffusing capacity for carbon monoxide corrected for alveolar volume, DSS Disease severity score, FEV1 Forced expiratory volume in the first second, FVC Forced vital capacity, HCO3 Carbonic acid hydrogen radical, HCT Hematocrit, HGB Hemoglobin, pH Pondus hydrogenii, LDH Lactate dehydrogenase, PaCO2 Partial pressure of carbon dioxide, PaO2 Partial pressure of oxygen, RBC Red blood cell, RV Residual volume, SaO2 Oxygen saturation of blood, SGRQ St George Respiratory Questionnaire, TLC Total lung capacity